Showing results (111-120 of 183) with videos related to

Sort By:
Pageof 19
Journal of Chemical Information and Modeling|June 28, 2024
Exploring Structural Requirements for Sigma-1 Receptor Linear Ligands: Experimental and Computational ApproachesLisa Lombardo, Salvatore Mirabile, Rosaria Gitto, et al.
Frontiers in Medicine|January 28, 2026
Beyond the vision: central serous chorioretinopathy, anxiety and depression-a systematic reviewAlessandro Meduri, Emanuele Maria Merlo, Giorgio Sparacino, et al.
European Journal of Medicinal Chemistry|August 13, 2016
Computational and synthetic approaches for developing Lavendustin B derivatives as allosteric inhibitors of HIV-1 integraseFatima E Agharbaoui, Ashley C Hoyte, Stefania Ferro, et al.
Prenatal Diagnosis|December 20, 2023
Learning curve for fetal postmortem ultrasoundPatricia Ibarra Vilar, Laura De Luca, Dominique A Badr, et al.
Biomedicines|October 27, 2022
The SIRT2 Pathway Is Involved in the Antiproliferative Effect of Flavanones in Human Leukemia Monocytic THP-1 CellsCaterina Russo, Alessandro Maugeri, Laura De Luca, et al.
ACS Chemical Neuroscience|February 18, 2022
Discovery of Neuroprotective Agents Based on a 5-(4-Pyridinyl)-1,2,4-triazole ScaffoldRosaria Gitto, Serena Vittorio, Federica Bucolo, et al.
Journal of Medicinal Chemistry|December 28, 2002
Discovery of a novel and highly potent noncompetitive AMPA receptor antagonistRosaria Gitto, Maria Letizia Barreca, Laura De Luca, et al.
Bioorganic & Medicinal Chemistry|April 22, 2020
Discovery of a new potent inhibitor of mushroom tyrosinase (Agaricus bisporus) containing 4-(4-hydroxyphenyl)piperazin-1-yl moietyLaura De Luca, Maria Paola Germanò, Antonella Fais, et al.
Chemical Biology & Drug Design|May 6, 2018
Discovery of benzimidazole-based Leishmania mexicana cysteine protease CPB2.8ΔCTE inhibitors as potential therapeutics for leishmaniasisLaura De Luca, Stefania Ferro, Maria Rosa Buemi, et al.
Bioorganic & Medicinal Chemistry|January 26, 2010
Novel 1,3-dihydro-benzimidazol-2-ones and their analogues as potent non-nucleoside HIV-1 reverse transcriptase inhibitorsAnna-Maria Monforte, Patrizia Logoteta, Laura De Luca, et al.
Pageof 19